AI assistant
Sending…
SOLIGENIX, INC. — Director's Dealing 2009
Oct 13, 2009
35119_dirs_2009-10-13_fdee311a-3769-47b9-9046-24d868aa92c2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2009-10-08
Reporting Person: Rubin Robert Joseph (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-10-08 | Stock Options (right to buy) | $.31 | A | 300000 | Acquired | 2019-10-07 | Common Stock (300000) | Direct |
Footnotes
F1: As a new Board member, the Company granted Dr. Rubin options to purchase 300,000 shares of the Company's common stock at a strike price of $0.31 with an expiration date of October 7, 2019. All options vested on October 8, 2009.
More from SOLIGENIX, INC.
Regulatory Filings
2026
May 28
Capital/Financing Update
2026
May 28
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Capital/Financing Update
2026
May 8
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3